Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
829.37
962.80
1,448.79
1,553.83
1,162.77
1,360.61
995.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
829.37
962.80
1,448.79
1,553.83
1,162.77
1,360.61
995.45
Raw Material Cost
685.21
733.53
993.50
1,218.40
826.91
1,063.90
665.82
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
115.69
131.14
133.58
121.89
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.80
0.63
0.95
2.72
1.68
0.59
0.47
Selling and Distribution Expenses
72.75
166.45
238.23
156.98
152.63
132.91
117.64
Other Expenses
-8.54
-9.44
-9.75
-7.51
4.20
5.01
2.15
Total Expenditure (Excl Depreciation)
789.06
937.37
1,268.79
1,424.93
1,023.17
1,247.49
805.39
Operating Profit (PBDIT) excl Other Income
40.300000000000004
25.4
180
128.9
139.60000000000002
113.10000000000001
190.10000000000002
Other Income
50.81
87.90
53.40
21.77
23.66
19.25
28.92
Operating Profit (PBDIT)
202.57
247.36
346.63
261.82
272.74
243.38
298.36
Interest
0.80
0.63
0.95
2.72
1.68
0.59
0.47
Exceptional Items
-22.81
-108.15
-58.01
-16.91
-30.15
-15.65
-6.03
Gross Profit (PBDT)
144.16
229.28
455.29
335.43
335.86
296.71
329.63
Depreciation
112.83
135.18
123.57
115.96
113.07
112.76
79.80
Profit Before Tax
66.13
3.39
164.10
126.23
127.84
114.38
212.06
Tax
11.15
34.47
20.34
10.81
11.92
9.44
33.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
61.77
-12.31
140.16
111.42
105.56
89.93
178.58
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
61.77
-12.31
140.16
111.42
105.56
89.93
178.58
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.06
-16.10
-7.63
7.63
13.10
16.98
0.32
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
59.71
-28.41
132.53
119.05
118.66
106.91
178.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,993.78
1,983.91
2,017.38
1,865.92
1,755.71
1,612.90
1,579.90
Earnings per share (EPS)
0.21
-0.04
0.48
0.38
0.37
0.31
0.62
Diluted Earnings per share
0.21
-0.04
0.48
0.38
0.37
0.31
0.62
Operating Profit Margin (Excl OI)
4.69%
2.52%
11.71%
7.99%
11.7%
8.19%
19.05%
Gross Profit Margin
21.58%
14.39%
19.86%
15.59%
20.72%
16.69%
29.32%
PAT Margin
7.45%
-1.28%
9.67%
7.17%
9.08%
6.61%
17.94%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -13.86% vs -33.55% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 310.21% vs -121.43% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -4.83% vs -45.60% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 33.33% vs -33.33% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Qianjiang Yongan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
829.37
0
829.37
Other Operating Income
0.00
0.00
0.00
Total Operating income
829.37
0
829.37
Raw Material Cost
685.21
0
685.21
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
115.69
0
115.69
Power Cost
0
0
0.00
Manufacturing Expenses
0.80
0
0.80
Selling and Distribution Expenses
72.75
0
72.75
Other Expenses
-8.54
0.00
-8.54
Total Expenditure (Excl Depreciation)
789.06
0
789.06
Operating Profit (PBDIT) excl Other Income
40.31
0.00
40.31
Other Income
50.81
0
50.81
Operating Profit (PBDIT)
202.57
0
202.57
Interest
0.80
0
0.80
Exceptional Items
-22.81
0
-22.81
Gross Profit (PBDT)
144.16
0
144.16
Depreciation
112.83
0
112.83
Profit Before Tax
66.13
0
66.13
Tax
11.15
0
11.15
Provisions and contingencies
0
0
0.00
Profit After Tax
61.77
0
61.77
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
61.77
0
61.77
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.06
0
-2.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
59.71
0
59.71
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,993.78
0
1,993.78
Earnings per share (EPS)
0.21
0
0.21
Diluted Earnings per share
0.21
0
0.21
Operating Profit Margin (Excl OI)
4.69%
0%
0.00
4.69%
Gross Profit Margin
21.58%
0%
0.00
21.58%
PAT Margin
7.45%
0%
0.00
7.45%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 82.94 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -13.86% vs -33.55% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 5.97 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 310.21% vs -121.43% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.18 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -4.83% vs -45.60% in Dec 2023
Annual - Interest
Interest 0.08 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 33.33% vs -33.33% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.69%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
